Blood Agar Base (Infusion Agar) : Intended Use
Blood Agar Base (Infusion Agar) : Intended Use
Intended Use:
Blood Agar Base is recommended as a base to which blood may be added for use in the isolation and cultivation of
fastidious pathogenic microorganisms like Neisseria , Streptococci etc.
Composition**
Ingredients Gms / Litre
HM peptone B# 10.000
Tryptose 10.000
Sodium chloride 5.000
Agar 15.000
Final pH ( at 25°C) 7.3±0.2
**Formula adjusted, standardized to suit performance parameters
# Equivalent to Beef Heart peptone
Directions
Suspend 40.0 grams in 1000 ml distilled water. Heat to boiling to dissolve the medium completely. Sterilize by autoclaving
at 15 lbs pressure (121°C) for 15 minutes. Cool to 45-50°C and aseptically add 5% v/v sterile defibrinated blood. Mix well
and pour into sterile Petri plates.
Type of specimen
Clinical material : blood and other pathological material ; food samples
Limitations
1.Addition of sheep blood is recommended to detect haemolysis. This medium does not support the growth of H.haemolyticus
2.Addition of Horse blood or rabbit blood to base medium supports growth of H.haemolyticus but resemble beta-
haemolytic Streptococci and hence must be confirmed.
3. Haemolytic pattern varies with the source of blood used.
Quality Control
Appearance
Cream to yellow homogeneous free flowing powder
Gelling
Firm, comparable with 1.5% Agar gel
Colour and Clarity of prepared medium
Basal medium : Light amber coloured clear to slightly opalescent gel. After addition of 5% v/v sterile defibrinated blood :
Cherry red coloured opaque gel forms in Petri plates.
Reaction
Reaction of 4.0% w/v aqueous solution at 25°C. pH : 7.3±0.2
pH
7.10-7.50
Cultural Response
Cultural characteristics observed with added 5% w/v sterile defibrinated blood,after an incubation at 35-37°C for 18-48
hours.
Organism Inoculum Growth w/o Recovery w/o Growth with Recovery with Haemolysis
(CFU) blood blood blood blood
Cultural Response
Neisseria meningitidis ATCC 50-100 fair 40-50% luxuriant >=70% none
13090
Staphylococcus aureus 50-100 good 50-70% luxuriant >=70% beta
subsp. aureus ATCC
25923 (00034*)
Disposal
User must ensure safe disposal by autoclaving and/or incineration of used or unusable preparations of this product. Follow
established laboratory procedures in disposing of infectious materials and material that comes into contact with clinical
sample must be decontaminated and disposed of in accordance with current laboratory techniques (10,11).
Reference
1. Noble W. C., 1962, J. Clin, Pathol., 15:552.
2. Hansen N. H., 1962, J. Appl. Bacteriol., 25:46.
3. Hayes P. R., 1963, J. Gen. Microbiol., 30:1.
4. Schuber J. H., Edwards P. R. and Ramsere C. H., 1959, J. Bacteriol., 77:648.
5. Salfinger Y., and Tortorello M.L. Fifth (Ed.), 2015, Compendium of Methods for the Microbiological Examination of
Foods, 5th Ed., American Public Health Association, Washington, D.C.
6.U.S. Food and Drug Administration, 1995, Bacteriological Analytical Manual, 8th Ed., AOAC International, Gaithersburg,
Md.
7.Atlas R. M., 1993, Handbook of Microbiology of Microbiological Media, CRC Press, Boca Raton, Fla.
8.Snavely J. G. and Brahier J., 1960, Am. J. Clin. Pathol., 33:511.
9.Murray P. R., Baron J. H., Jorgensen J. H., Pfaller M. A., Yolken R. H., (Eds.), 8th Ed., 2003, Manual of Clinical
Microbiology, ASM, Washington, D.C.
10.Isenberg, H.D. Clinical Microbiology Procedures Handb0ook. 2nd Editio
11. Jorgensen,J.H., Pfaller , M.A., Carroll, K.C., Funke, G., Landry, M.L., Richter, S.S and Warnock., D.W. (2015)
Manual Clinical Microbiology, 11th Edition. Vol. 1.
Revision : 03 / 2018
CE Marking
10°C
Disclaimer :
User must ensure suitability of the product(s) in their application prior to use. Products conform solely to the information contained in
this and other related HiMedia™ publications. The information contained in this publication is based on our research and development
work and is to the best of our knowledge true and accurate. HiMedia™ Laboratories Pvt Ltd reserves the right to make changes to
specifications and information related to the products at any time. Products are not intended for human or animal or therapeutic use but
for laboratory,diagnostic, research or further manufacturing use only, unless otherwise specified. Statements contained herein should not
be considered as a warranty of any kind, expressed or implied, and no liability is accepted for infringement of any patents.
HiMedia Laboratories Pvt. Ltd. Reg.office : 23, Vadhani Ind.Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6116 9797 Corporate office :
A-516,Swastik Disha Business Park,Via Vadhani Ind. Est., LBS Marg, Mumbai-400086, India. Customer care No.: 022-6147 1919 Email:
techhelp@himedialabs.com Website: www.himedialabs.com